跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,102 条关于
“oxyntomodulin analog”
全部
2,102
临床试验
1,423
药物
332
机构
12
资讯
335
10个月前
MetaVia's DA-1726 Shows Promising Weight Loss Results in Phase 1 Trial with Superior Lipid Benefits
去年
OPKO Health and Entera Bio Advance First-in-Class Oral Dual GLP-1/Glucagon Tablet for Obesity Treatment
去年
Entera Bio and OPKO Health Announce Positive PK/PD Results for Oral Oxyntomodulin for Obesity and Metabolic Disorders
去年
OPKO Health and Entera Bio Collaborate to Develop First Oral GLP-1/Glucagon Dual Agonist for Obesity Treatment
2年前
Altimmune's Pemvidutide Projected to Reach $759M in Global Sales by 2039
2年前
NeuroBo Pharmaceuticals Completes Enrollment in Phase 1 Trial of DA-1726 for Obesity
8个月前
MetaVia's DA-1726 Demonstrates 9.1% Weight Loss and Significant Metabolic Benefits in Phase 1b Obesity Trial
去年
Innovent to Present Phase 3 Results of Dual GLP-1/Glucagon Receptor Agonist Mazdutide at ADA 2025
去年
Innovent Initiates Head-to-Head Phase 3 Trial of Mazdutide vs Semaglutide for Obesity with Fatty Liver Disease
去年
MetaVia's Novel Dual Receptor Agonist Shows Promising 6.3% Weight Loss in Phase 1 Obesity Trial
第 1 页,共 34 页
上一页
下一页